- Home
- HUIZ vs LSB Comparison
HUIZ vs LSB Comparison
Compare HUIZ & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- LSB
- Stock Information
- Founded
- HUIZ 2006
- LSB 2002
- Country
- HUIZ China
- LSB China
- Employees
- HUIZ N/A
- LSB N/A
- Industry
- HUIZ Specialty Insurers
- LSB
- Sector
- HUIZ Finance
- LSB
- Exchange
- HUIZ Nasdaq
- LSB NYSE
- Market Cap
- HUIZ 20.8M
- LSB 20.4M
- IPO Year
- HUIZ 2020
- LSB N/A
- Fundamental
- Price
- HUIZ $2.80
- LSB $1.04
- Analyst Decision
- HUIZ Hold
- LSB
- Analyst Count
- HUIZ 1
- LSB 0
- Target Price
- HUIZ $2.30
- LSB N/A
- AVG Volume (30 Days)
- HUIZ 17.7K
- LSB 841.1K
- Earning Date
- HUIZ 06-06-2025
- LSB 07-29-2025
- Dividend Yield
- HUIZ N/A
- LSB N/A
- EPS Growth
- HUIZ N/A
- LSB N/A
- EPS
- HUIZ N/A
- LSB N/A
- Revenue
- HUIZ $168,454,627.00
- LSB $79,415,311.00
- Revenue This Year
- HUIZ $11.94
- LSB $39.33
- Revenue Next Year
- HUIZ $8.15
- LSB $75.61
- P/E Ratio
- HUIZ N/A
- LSB N/A
- Revenue Growth
- HUIZ 1.28
- LSB N/A
- 52 Week Low
- HUIZ $1.50
- LSB $0.36
- 52 Week High
- HUIZ $10.58
- LSB $6.82
- Technical
- Relative Strength Index (RSI)
- HUIZ 73.35
- LSB 48.03
- Support Level
- HUIZ $2.11
- LSB $1.01
- Resistance Level
- HUIZ $3.00
- LSB $1.16
- Average True Range (ATR)
- HUIZ 0.24
- LSB 0.12
- MACD
- HUIZ 0.07
- LSB 0.01
- Stochastic Oscillator
- HUIZ 80.62
- LSB 20.00
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.